Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

• Main Authors: Edward A. Stadtmauer (Author), Keith M. Sullivan (Author), Mohamed El Idrissi (Author), Bruno Salaun (Author), Aránzazu Alonso Alonso (Author), Charalambos Andreadis (Author), Veli-Jukka Anttila (Author), Adrian JC Bloor (Author), Raewyn Broady (Author), Claudia Cellini (Author), Antonio Cuneo (Author), Alemnew F. Dagnew (Author), Emmanuel Di Paolo (Author), HyeonSeok Eom (Author), Ana Pilar González-Rodríguez (Author), Andrew Grigg (Author), Andreas Guenther (Author), Thomas C. Heineman (Author), Isidro Jarque (Author), Jae-Yong Kwak (Author), Alessandro Lucchesi (Author), Lidia Oostvogels (Author), Marta Polo Zarzuela (Author), Anne E. Schuind (Author), Thomas C. Shea (Author), Ulla Marjatta Sinisalo (Author), Filiz Vural (Author), Lucrecia Yáñez San Segundo (Author), Pierre Zachée (Author), Adriana Bastidas (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immunocompromised individuals, particularly autologous hematopoietic stem cell transplant (auHSCT) recipients, are at high risk for herpes zoster (HZ). We provide an in-depth description of humoral and cell-mediated immune (CMI) responses by age (protocol-defined) or underlying disease (post-hoc) as...